RT Journal Article
T1 COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases.
A1 Lopez-Medina, Clementina
A1 Escudero, Alejandro
A1 Collantes-Estevez, Eduardo
K1 Outcome and process assessment, health care
K1 Outcome assessment, health care
K1 Quality indicators, health care
AB We read with interest the letter published by Bozzalla Cassione et al, 1  in which authors evaluated 165 patients with systemic lupus erythematosus using telemedicine as the follow-up method. As in Italy, the high infectivity and the risk of collapse of intensive care units led to the Spanish government to announce on 14 March the strict confinement and prohibition of social mobility to ensure a decrease in COVID-19 contagion rates.
PB BMJ Group
YR 2020
FD 2020-05-19
LK http://hdl.handle.net/10668/15691
UL http://hdl.handle.net/10668/15691
LA en
NO López-Medina C, Escudero A, Collantes-Estevez E. COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases. Ann Rheum Dis. 2021 Apr;80(4):e50
NO López-Medina C, Escudero A, Collantes-Estevez E. COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases. Ann Rheum Dis. 2021 Apr;80(4):e50
DS RISalud
RD Apr 19, 2025